Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors

Since target therapy with mTOR inhibitors plays an important role in the current management of clear cell renal cell carcinoma (RCC), there is an increasing demand for predictive biomarkers, which may help to select patients that are most likely to benefit from personalized treatment. When dealing w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Cancer Res
Prif Awduron: Fiorini, Claudia, Massari, Francesco, Pedron, Serena, Sanavio, Sara, Ciccarese, Chiara, Porcaro, Antonio Benito, Artibani, Walter, Bertoldo, Francesco, Zampini, Claudia, Sava, Teodoro, Ficial, Miriam, Caliò, Anna, Chilosi, Marco, D’Amuri, Alessandro, Sanguedolce, Francesca, Tortora, Giampaolo, Scarpa, Aldo, Delahunt, Brett, Porta, Camillo, Martignoni, Guido, Brunelli, Matteo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: e-Century Publishing Corporation 2014
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4266722/
https://ncbi.nlm.nih.gov/pubmed/25520878
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg